Literature DB >> 18936900

[HPV vaccination is important for dermatologists].

G Gross1.   

Abstract

The quadrivalent prophylactic HPV vaccination against HPV types 6, 11, 16 and 18 is not only highly effective in preventing HPV 16 and 18-associated cervical cancer, precancerous cervical lesions and high-grade precancerous vulvar and vaginal lesions but also against HPV 6 and 11-associated genital warts. Therefore, HPV-vaccination clearly belongs to the dermatologists' field of responsibility. A survey among 770 German dermatologists showed broad acceptance of the HPV vaccination; two-thirds of the persons asked would recommend the vaccination to their patients, regardless of reimbursement or STIKO recommendation, if they are convinced of the medical benefit. The survey also showed that HPV vaccination has not yet been fully established among dermatologists. Taking the high efficacy of the quadrivalent HPV vaccine into account, dermatologists should actively offer the HPV vaccination to their patients. The current AWMF-S3-guideline "Impfprävention HPV-assoziierter Neoplasien"can be used as a decision-making basis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936900     DOI: 10.1007/s00105-008-1618-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

Review 1.  The management of difficult anogenital warts.

Authors:  A McMillan
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

Review 2.  Management of anogenital warts (condylomata acuminata).

Authors:  G von Krogh
Journal:  Eur J Dermatol       Date:  2001 Nov-Dec       Impact factor: 3.328

3.  Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

Authors:  Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

4.  A population-based study of squamous cell vaginal cancer: HPV and cofactors.

Authors:  Janet R Daling; Margaret M Madeleine; Stephen M Schwartz; Katherine A Shera; Joseph J Carter; Barbara McKnight; Peggy L Porter; Denise A Galloway; James K McDougall; Hisham Tamimi
Journal:  Gynecol Oncol       Date:  2002-02       Impact factor: 5.482

Review 5.  Vulval intraepithelial neoplasia: current perspectives.

Authors:  R W Jones
Journal:  Eur J Gynaecol Oncol       Date:  2001       Impact factor: 0.196

6.  Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double-blind study in 120 patients.

Authors:  G Gross; T Rogozinski; H Schöfer; S Jabłońska; A Roussaki; C Wöhr; J Brzoska
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

Review 7.  [Impact of prophylactic HPV vaccines on dermatology and venereology].

Authors:  G Gross
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

8.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

9.  The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

Authors:  Susanne Krüger Kjaer; Trung Nam Tran; Par Sparen; Laufey Tryggvadottir; Christian Munk; Erik Dasbach; Kai-Li Liaw; Jan Nygård; Mari Nygård
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

10.  A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population.

Authors:  Zheng Zeng; Li Guan; Ping An; Shan Sun; Stephen J O'Brien; Cheryl A Winkler
Journal:  BMC Infect Dis       Date:  2008-01-02       Impact factor: 3.090

View more
  1 in total

1.  [Conservative treatment of anogenital HPV infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.